Introduction
Materials and methods
Eligibility criteria
Outcome assessment
Costing methodology
Cost-outcome descriptions
Statistics
Results
Patient outcomes
Cardiac arrest (n = 354) | Hospital non-survivors (n = 204) | Completed questionnaire (n = 81) | GCS score below 6 points (n = 7) | |
---|---|---|---|---|
Age in years, mean ± SD | 66 ± 13 | 68 ± 12 | 61 ± 13 | 61 ± 12 |
Median (25th/75th percentile) | 68 (60/75) | 70 (62/77) | 61 (53/72) | 64 (50/68) |
Gender male/female, number (percentage) | 252/102 (71/29) | 148/56 (73/27) | 57/24 (70/30) | 6/1 (86/14) |
ICU stay in days, mean ± SD (minimum-maximum) | 9 ± 16 (1–113) | 8 ± 14 (1–98) | 7 ± 11 (1–78) | 17 ± 23 (2–67) |
Median (25th/75th percentile) | 3 (1/9) | 4 (1/9) | 3 (2/7) | 6 (2/18) |
Hospital stay in days, mean ± SD (minimum-maximum) | 25 ± 28 (1–176) | 4 ± 18 (1–150)a | 19 ± 18 (1–103) | 35 ± 30 (2–101) |
Median (25th/75th percentile) | 15 (5/33) | NA | 14 (10/22) | 26 (15/38) |
SAPS II, mean ± SD | 47 ± 23 | 58 ± 19a | 38 ± 20 | 47 ± 21 |
Median (25th/75th percentile) | 45 (31/63) | 58 (44/71)a | 33 (23/53) | 53 (24/66) |
SAPS II PRM as a percentage, mean ± SD | 42 ± 33 | 58 ± 30a | 42 ± 33 | 45 ± 36 |
Median (25th/75th percentile) | 35 (12/74) | 64 (33/85)a | 14 (5/52) | 53 (6/78) |
Simplified TISS-28 day 1, mean ± SD | 34 ± 11 | 36 ± 10 | 31 ± 8 | 37 ± 3 |
Median (25th/75th percentile) | 34 (28/40) | 36 (28/43) | 32 (26/37) | 37 (34/40) |
TMS, mean ± SD | 9.6 ± 5.2 | 11.8 ± 4.5a | 6.3 ± 5.0 | 7.7 ± 5.3 |
Median (25th/75th percentile) | 11 (5/13) | 13 (10/15)a | 5 (2/11) | 9 (1/10) |
Costs
Mean | Range | 95% confidence interval | |
---|---|---|---|
Total ICU costs per patient | 17,832 € | 1,708 to 181,500 € | 15,280 to 20,390 € |
Daily ICU costs per patient | 2,693 € | 656 to 5,856 € | 2,555 to 2,832 € |
Mean | SD | Median (interquartile range) | |
---|---|---|---|
Daily ICU costs per patient | 2,285 € | 638 € | 2,012 € (1,887 €/2,934 €) |
Total hospital costs per patient | 35,910 € | 37,579 € | 18,297 € (14,648 €/33,253 €) |
Post-hospital costs per patient | 132,565 € | 59,878 € | 122,945 € (91,094 €/186,888 €) |
Nursing home costs per patient | 654,480 € | 362,880 € | 534,600 € (405,000 €/988,200 €) |
Costs per survivor and costs per long-term survivor
Costs per life years gained
Costs per quality-adjusted life year
Discussion
Critically ill | Costs per quality-adjusted life year |
---|---|
Hamel, et al. (2000) [36] | Low-risk group (likelihood of surviving 2 months, >70%): 28,889 € |
Mechanical ventilation for acute respiratory failure due to pneumonia or Adult Respiratory Distress Syndrome versus mechanical ventilation withheld | Medium-risk group (likelihood of surviving 2 months, 51% to 70%): 43,832 € |
High-risk group (likelihood of surviving 2 months, <50%): 109,582 € | |
Hamel, et al. (1997) [37] | Average costs: 143,742 € |
Initiating dialysis and continuing aggressive care in seriously ill patients versus withholding renal support therapy | Best prognostic category: 69,404 € |
Worst prognostic category: 307,329 € | |
Paniagua, et al. (2002) [38] | Quality of life estimated: 84,365 € |
Cardiopulmonary resuscitation for in-hospital cardiac arrest in octogenarians followed by aggressive treatment | |
Non-ICU patients | |
CDC Diabetes Cost-effectiveness Group (2002) [39] | Intensive glycemic control: 42,463 € |
Reducing complications in patients with type 2 diabetes using various interventions | Reducing serum cholesterol level: 53,242 € |
Intensified hypertension control saves 2,010 € | |
Wonderling, et al. (2004) [40] | 13,311 € |
Acupuncture for chronic headache in primary care versus usual care only | |
Brunner-La Rocca, et al. (2007) [41] | 40,467 € |
Drug-eluting stents versus bare-metal stents in percutaneous coronary interventions |
Conclusion
Key messages
-
Patients who leave the hospital following cardiac arrest without severe neurological disabilities may expect fair long-term survival and a good quality of life.
-
Costs per life year gained and costs per quality-adjusted life year in survivors after cardiac arrest are acceptable.
-
Expenses to the health care system are reasonable compared with other interventions carried out in both intensive care unit (ICU) and non-ICU patients.